377 related articles for article (PubMed ID: 19357147)
1. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients.
Ferland A; Poirier P; Sériès F
Eur Respir J; 2009 Sep; 34(3):694-701. PubMed ID: 19357147
[TBL] [Abstract][Full Text] [Related]
2. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea.
Yee BJ; Phillips CL; Banerjee D; Caterson I; Hedner JA; Grunstein RR
Int J Obes (Lond); 2007 Jan; 31(1):161-8. PubMed ID: 16652122
[TBL] [Abstract][Full Text] [Related]
3. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.
Durán-Cantolla J; Aizpuru F; Montserrat JM; Ballester E; Terán-Santos J; Aguirregomoscorta JI; Gonzalez M; Lloberes P; Masa JF; De La Peña M; Carrizo S; Mayos M; Barbé F;
BMJ; 2010 Nov; 341():c5991. PubMed ID: 21106625
[TBL] [Abstract][Full Text] [Related]
4. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
[TBL] [Abstract][Full Text] [Related]
5. Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea.
Salord N; Mayos M; Miralda RM; Farré A; Carreras M; Sust R; Masuet-Aumatell C; Rodríguez J; Pérez A
Respirology; 2013 Oct; 18(7):1135-42. PubMed ID: 23714281
[TBL] [Abstract][Full Text] [Related]
6. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP.
Bonsignore MR; Parati G; Insalaco G; Castiglioni P; Marrone O; Romano S; Salvaggio A; Mancia G; Bonsignore G; Di Rienzo M
Eur Respir J; 2006 Jan; 27(1):128-35. PubMed ID: 16387945
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of autoadjusting and fixed continuous positive airway pressure treatments on cardiorespiratory coupling in obese patients with obstructive sleep apnea.
Patruno V; Tobaldini E; Bianchi AM; Mendez MO; Coletti O; Costantino G; Montano N
Eur J Intern Med; 2014 Feb; 25(2):164-8. PubMed ID: 24373628
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
[TBL] [Abstract][Full Text] [Related]
10. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs.
Börgel J; Sanner BM; Keskin F; Bittlinsky A; Bartels NK; Büchner N; Huesing A; Rump LC; Mügge A
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1081-7. PubMed ID: 15607612
[TBL] [Abstract][Full Text] [Related]
11. The differences in sleep profile changes under continuous positive airway pressure (CPAP) therapy between non-obese, obese and severely obese sleep apnea patients.
Antczak J; Horn B; Richter A; Bodenschatz R; Latuszynski K; Schmidt EW; Jernajczyk W
J Physiol Pharmacol; 2012 Jun; 63(3):263-9. PubMed ID: 22791640
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
13. Atrial overdrive pacing compared to CPAP in patients with obstructive sleep apnoea syndrome.
Unterberg C; Lüthje L; Szych J; Vollmann D; Hasenfuss G; Andreas S
Eur Heart J; 2005 Dec; 26(23):2568-75. PubMed ID: 16126716
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
[TBL] [Abstract][Full Text] [Related]
15. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome.
Noda A; Nakata S; Koike Y; Miyata S; Kitaichi K; Nishizawa T; Nagata K; Yasuma F; Murohara T; Yokota M
Hypertens Res; 2007 Aug; 30(8):669-76. PubMed ID: 17917313
[TBL] [Abstract][Full Text] [Related]
16. [Influence of nasal continuous positive airway pressure on response to exercise in patients with obstructive sleep apnea syndrome].
Przybyłowski T; Bielicki P; Kumor M; Hildebrand K; Maskey-Warzechowska M; Wiwała J; Kościuch J; Korczyński P; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):39-44. PubMed ID: 17175974
[TBL] [Abstract][Full Text] [Related]
17. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
19. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
Craig S; Pepperell JC; Kohler M; Crosthwaite N; Davies RJ; Stradling JR
J Sleep Res; 2009 Sep; 18(3):329-36. PubMed ID: 19549077
[TBL] [Abstract][Full Text] [Related]
20. Polysomnographic profile in a sleep laboratory in Kolkata: a retrospective analysis of 714 cases.
Ghoshal AG; Sarkar S; Roy DJ; Das RK; Ray M
J Assoc Physicians India; 2010 Jul; 58():415-9. PubMed ID: 21121205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
